London-based insurtech company Artificial Labs has raised $45 million in a Series B funding round as it looks to scale its digital broking and underwriting platform for commercial and speciality insurance markets.
The round was led by CommerzVentures, with participation from Move Capital Fund I and continued backing from existing investors. Artificial did not disclose its valuation. Alongside CommerzVentures and Move Capital Fund I, the Series B round includes continued support from existing investors Augmentum Fintech, 6 Degrees Capital, FOM, and TrueSight Ventures.
According to the company, the new funding provides it with the financial headroom to grow at scale while keeping pace with the needs of large brokers and insurance carriers.
“This round gives us the room to grow with confidence. The investment allows us to scale in a way that keeps pace with our clients. We have the teams, the technology, and the stability to support the largest brokers and carriers as they modernise how they operate,” said David King, Co-Founder of Artificial.
Over the next 12 months, Artificial expects to double its team size. The company also plans to expand into the US market in 2026, while continuing to strengthen its position in the London insurance market.
Solving long-standing insurance challenges
Artificial Labs provides digital tools that help brokers and insurers modernise how risks are placed, underwritten, and traded. The company says its platform is designed to address long-standing inefficiencies in commercial and speciality insurance workflows.
“We have built a platform that solves real problems for insurance. With this investment, we will grow our team, continue to innovate, and ensure that Artificial remains the natural choice for brokers and carriers seeking a smarter way to trade digitally,” said Johnny Bridges, Co-Founder of Artificial.
“We are thrilled to support Artificial as they extend their leadership globally,” says Heiko Schwender, Managing Partner at CommerzVentures. “We have been backing next-generation technology businesses for more than a decade. Artificial’s platform addresses a real, structural problem that has constrained efficiency in commercial and speciality insurance for decades. The team’s combination of deep insurance domain expertise and world-class engineering is rare, and it uniquely positions them to redefine this market.”
“Artificial benefits from a rare blend of deep insurance expertise, strong client relationships and highly innovative technology. The company is ideally positioned to address bottleneck challenges for speciality risk placement players globally, which reflects Move Capital’s conviction in platforms that turn domain expertise into scalable, data-driven operational execution,” says Hervé Malausséna, Founding Partner at Move Capital Fund I.
